BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 359598)

  • 1. Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity.
    Kelton JG; Hirsh J; Carter CJ; Buchanan MR
    J Clin Invest; 1978 Oct; 62(4):892-5. PubMed ID: 359598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shortening of the bleeding time in rabbits by hydrocortisone caused by inhibition of prostacyclin generation by the vessel wall.
    Blajchman MA; Senyi AF; Hirsh J; Surya Y; Buchanan M; Mustard JF
    J Clin Invest; 1979 May; 63(5):1026-35. PubMed ID: 376547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced platelet accumulation onto injured carotid arteries in rabbits after aspirin treatment.
    Buchanan MR; Dejana E; Gent M; Mustard JF; Hirsch J
    J Clin Invest; 1981 Feb; 67(2):503-8. PubMed ID: 7007438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombogenic properties of the vessel and their inhibition].
    Cazenave JP; Klein-Soyer C; Beretz A
    Nouv Rev Fr Hematol (1978); 1982; 24(3):167-71. PubMed ID: 6752880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin.
    Jaffe EA; Weksler BB
    J Clin Invest; 1979 Mar; 63(3):532-5. PubMed ID: 372242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aspirin and sodium salicylate on thrombosis, fibrinolysis, prothrombin time, and platelet survival In rabbits with indwelling aortic catheters.
    Cattaneo M; Chahil A; Somers D; Kinlough-Rathbone RL; Packham MA; Mustard JF
    Blood; 1983 Feb; 61(2):353-61. PubMed ID: 6821701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
    J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits.
    Buchanan MR; Hirsh J
    Arteriosclerosis; 1984; 4(4):403-6. PubMed ID: 6380468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B; Fareed J
    Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function.
    Cerletti C; Bonati M; del Maschio A; Galletti F; Dejana E; Tognoni G; de Gaetano G
    J Lab Clin Med; 1984 Jun; 103(6):869-77. PubMed ID: 6726057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of arterial PGI2 generation and platelet aggregation by aspirin in rabbits ex vivo.
    Basista M
    Pol J Pharmacol Pharm; 1982; 34(5-6):317-21. PubMed ID: 6821216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.
    Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM
    Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Venous prostacycline synthesis and plasma thromboxane B2 after low-dose aspirin].
    Kaliman J; Cromwell M; Sinzinger H
    Wien Klin Wochenschr; 1983 Sep; 95(17):615-7. PubMed ID: 6359724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits.
    Ellis EF; Wright KF; Jones PS; Richardson DW; Ellis CK
    J Cardiovasc Pharmacol; 1980; 2(4):387-97. PubMed ID: 6156337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of acetylsalicyclic and nicotinic acids and complamin on the formation of a prostacyclin-like substance by the aortic wall].
    Lakin KM; Baluda VP; Lukoianova TI; Romanovskaia VN; Baluda MV
    Farmakol Toksikol; 1980; 43(5):581-5. PubMed ID: 7004908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet adhesion and mural platelet thrombus formation on aortic subendothelium of rats, rabbits, and guinea pigs correlate negatively with the vascular PGI2 production.
    Tschopp TB; Baumgartner HR
    J Lab Clin Med; 1981 Sep; 98(3):402-11. PubMed ID: 7021720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
    Vilahur G; CasanĂ­ L; Badimon L
    Thromb Haemost; 2007 Sep; 98(3):662-9. PubMed ID: 17849057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
    Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G
    J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.